WallStSmart
KMDA

Kamada

NASDAQ: KMDA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$8.14
+0.37% today

Updated 2026-04-30

Market cap
$474.09M
P/E ratio
23.43
P/S ratio
2.63x
EPS (TTM)
$0.35
Dividend yield
3.05%
52W range
$6 – $9
Volume
0.1M

Kamada (KMDA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+75.3%
Last 4 quarters
Revenue YoY growth
+16.9%
Most recent quarter
EPS YoY growth
-14.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+1.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+6.0%
2025-11-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-18$0.06-40.0%$8.89$8.62-3.0%
2025-11-10$0.29+222.2%$6.66$7.06+6.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.10$0.06-40.0%$45.60M+16.9%
2025-09-30$0.09$0.29+222.2%$47.01M+12.6%
2025-06-30$0.08$0.19+137.5%$44.75M+5.4%
2025-03-31$0.07$0.07+3.7%$44.02M+16.6%
2024-12-31$0.05$0.07+31.3%$39.01M+7.1%
2024-09-30$0.07$0.07+0.0%$41.74M+10.0%
2024-06-30$0.06$0.08+33.3%$42.47M+13.4%
2024-03-31$0.06$0.04-33.3%$37.74M+22.9%
2023-12-31$0.05$0.09+80.0%$36.43M
2023-09-30$0.03$0.06+100.0%$37.93M
2023-06-30$0.02$0.04+100.0%$37.44M
2023-03-31$0.03$-0.04-233.3%$30.71M

Frequently asked questions

Has Kamada beaten earnings estimates?
Kamada has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +75.3% over the last 4 quarters.
How does KMDA stock react to earnings?
KMDA stock has moved an average of +1.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Kamada's revenue growth rate?
Kamada reported year-over-year revenue growth of +16.9% in its most recent quarter, with EPS growing -14.3% year-over-year.